Female adults
Conditions
Interventions
Oral consumption of one sachet of the test food dissolved in hot water once daily for 8 weeks.
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female aged 35 to below 65 years at the time of consent acquisition. 2. Individuals who are aware of having dry skin. 3. Individuals who are able to give informed consent to participate in this study after receiving a detailed explanation of the protocol and understanding its contents.
Exclusion criteria
Exclusion criteria: 1. Individuals who regularly consume Food for Specified Health Uses (FOSHU), functional foods, or health supplements (including those containing collagen, sodium hyaluronate, glucosyl ceramide, etc.) more than three times a week. 2. Individuals who cannot discontinue the intake of Food for Specified Health Uses (FOSHU), functional foods, or health supplements (including those containing collagen, sodium hyaluronate, glucosyl ceramide, etc.) from the time of consent. 3. Individuals using medications that could affect the trial outcomes, such as heparin analogs, urea, vaseline, or topical steroids. 4. Individuals with scars, bruises on measurement sites (left cheek, inner left forearm). 5. Individuals with skin irritation due to hay fever. 6. Individuals with extreme sunburn or those who engage in outdoor labor, work, or sports for extended periods. 7. Individuals planning a long-term overseas trip from the pre-test period through the end of the study. 8. Individuals receiving special care at external facilities for skin measurement areas (facial or body aesthetics, beauty devices, peeling, laser treatments, hair removal, etc.). 9. Individuals with excessive alcohol intake. 10. Individuals with previous and/or current medical history of serious diseases in the heart, liver, kidney, digestive organs. 11. Females who are pregnant or lactating, and those who intend to become pregnant during the trial period. 12. Individuals with allergies to medications and/or food. 13. Individuals who are participating in, have participated in within the four weeks prior to the current trial, or are planning to participate in clinical trials of pharmaceuticals or health foods. 14. Individuals who donated 200 mL of their blood or blood components within the last month. 15. Individuals who donated 400 mL of their blood within the last 4 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stratum corneum hydration Skin viscoelasticity Transepidermal water loss (TEWL) | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaire | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed